Literature DB >> 15787599

A genomic view of the complexity of mammalian proteolytic systems.

X S Puente1, L M Sánchez, A Gutiérrez-Fernández, G Velasco, C López-Otín.   

Abstract

Proteolytic enzymes play an essential role in different physiological processes, including development, reproduction and host defence, as well as in numerous pathologies, like inflammatory diseases, neurological disorders or cancer. The completion of the human genome sequence allowed us to determine that more than 2% of all human genes are proteases or protease inhibitors, reflecting the importance of proteolysis in human biology. To understand better the complexity of proteases in human and other model organisms, we have used the available genome sequences of different mammalian organisms, including mouse, rat and chimpanzee, to identify and compare their degradomes, the complete set of protease genes in these species. Surprisingly, the rodent protease complement is more complex when compared with that of primates, mainly due to the expansion of protease families implicated in reproduction and host defence. Similarly, most differences between human and chimpanzee proteases are found in genes implicated in the immune system, which might explain some of the differences between both organisms. We have also found several genes implicated in reproduction, nutrition and the immune system, which are functional in rat, mouse or chimpanzee, but have been inactivated by mutations in the human lineage. These findings suggest that pseudogenization of specific protease genes has been a mechanism contributing to the evolution of the human genome. Finally, we found that proteases implicated in human hereditary diseases, and especially in neurodegenerative disorders, are highly conserved among mammals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15787599     DOI: 10.1042/BST0330331

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  53 in total

1.  Kinetic dissection of the pre-existing conformational equilibrium in the trypsin fold.

Authors:  Austin D Vogt; Pradipta Chakraborty; Enrico Di Cera
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

2.  Why Ser and not Thr brokers catalysis in the trypsin fold.

Authors:  Leslie A Pelc; Zhiwei Chen; David W Gohara; Austin D Vogt; Nicola Pozzi; Enrico Di Cera
Journal:  Biochemistry       Date:  2015-02-11       Impact factor: 3.162

Review 3.  Proteases: multifunctional enzymes in life and disease.

Authors:  Carlos López-Otín; Judith S Bond
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

Review 4.  Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.

Authors:  M D Hollenberg; K Mihara; D Polley; J Y Suen; A Han; D P Fairlie; R Ramachandran
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 5.  Unconventional serine proteases: variations on the catalytic Ser/His/Asp triad configuration.

Authors:  Ozlem Doğan Ekici; Mark Paetzel; Ross E Dalbey
Journal:  Protein Sci       Date:  2008-09-29       Impact factor: 6.725

6.  Evolution of peptidase diversity.

Authors:  Michael J Page; Enrico Di Cera
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

7.  Engineering protease specificity made simple, but not simpler.

Authors:  Enrico Di Cera
Journal:  Nat Chem Biol       Date:  2008-05       Impact factor: 15.040

Review 8.  Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection.

Authors:  M D Hollenberg
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

Review 9.  Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.

Authors:  Ian M Carroll; Nitsan Maharshak
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

Review 10.  Serine proteases.

Authors:  Enrico Di Cera
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.